metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - all population
versus docetaxel
	avelumab alone vs. docetaxel	1	0.90 [0.75; 1.08], 1 RCT, I2=0% inconclusive result	1.16 [0.97; 1.39], 1 RCT, I2=0% inconclusive result	-